CORPUS CHRISTI, Texas — It's Heart Month, and today of all days is a reminder to take care of your heart. That's why we have some exciting news from CHRISTUS Spohn Shoreline! They're the only hospital ...

Instead, the 76-year-old Wahoo, Nebraska, woman underwent a procedure that repaired the valve via a blood vessel in her leg. A cardiologist threaded a catheter up into her heart and used a device ...

CHICAGO -- Emerging real-world data supported benefits of MitraClip therapy in patients with secondary mitral regurgitation (MR) who didn't fit the COAPT profile, the EXPAND study showed. MR was often ...

Transcatheter mitral valve repair for heart failure patients with mitral regurgitation can reduce the long-term rate of hospitalizations by almost 50 percent, and death by nearly 30 percent, compared ...

Surgical repair decreased MR more than MitraClip ®. In 12-month follow-up, 20% of MitraClip patients required surgery for mitral dysfunction versus 2% in surgical patients. Both groups had ...

Heart failure hospitalizations following MitraClip (Abbott) implantation for mitral regurgitation (MR) are markedly reduced, as compared with rates prior to the clip procedure, according to an ...

A new, large postapproval study provides reassurances that transcatheter edge-to-edge repair (TEER) is helpful in secondary mitral regurgitation (MR), and also shows that patients getting clipped aren ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window LONDON -- ...

n 2016, medical device giant Abbott issued a recall for its MitraClip cardiac device — "a Class I recall, the most serious type," the FDA said. "Use of this device may cause serious injuries or death, ...

Failed transcatheter edge-to-edge repair of functional and degenerative mitral regurgitation (MR) with the MitraClip (Abbott) is relatively uncommon at high-volume centers but associated with a high ...

In 2016, medical device giant Abbott issued a recall for its MitraClip cardiac device — “a Class I recall, the most serious type,” the FDA said. “Use of this device may cause serious injuries or death ...